ENDRA Life Sciences NDRA
$ 5.27
3.85%
Quarterly report 2024-Q2
added 08-14-2024
ENDRA Life Sciences Cash Flow 2011-2024 | NDRA
Annual Cash Flow ENDRA Life Sciences
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-9.55 M | -12.8 M | -11.1 M | -10.7 M | -8.59 M | -7.7 M | -3.3 M | -1.32 M | - | - | - | - | - |
Depreciation & Amortization |
124 K | 96.7 K | 116 K | 99.3 K | 80.6 K | 68.3 K | 61.5 K | 64.9 K | - | - | - | - | - |
Accounts Payables |
360 K | 614 K | 791 K | 403 K | 1.28 M | 631 K | 780 K | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | 6.85 K | - | - | - | - | - | - |
Total Inventories |
2.62 M | 2.64 M | 1.28 M | 590 K | 113 K | 59.4 K | 192 K | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow ENDRA Life Sciences
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -2.14 M | - | - | - | -2.51 M | - | -9.68 M | -6.43 M | -3.1 M | - | -8.47 M | -5.72 M | -2.92 M | - | -8.67 M | -6.54 M | -3.09 M | - | -6.68 M | -4.2 M | -2.54 M | - | -5.8 M | -4.33 M | -2.45 M | - | -1.93 M | -1.38 M | -236 K | - | -769 K | -769 K | -53.8 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | 15.3 K | - | 32.1 K | 35.3 K | 34.5 K | - | 64.5 K | 21.7 K | 19 K | - | 95 K | 65.2 K | 31.4 K | - | 45.1 K | 44 K | 21.6 K | - | 59.7 K | 39.7 K | 19.6 K | - | 48.2 K | 30.2 K | 15.3 K | - | 46.1 K | 31 K | 15.7 K | - | 48.6 K | 32.3 K | 16.2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
300 K | 522 K | 360 K | 419 K | 415 K | 524 K | 614 K | 637 K | 785 K | 834 K | 791 K | 748 K | 1.51 M | 807 K | 403 K | 403 K | 403 K | 403 K | 1.28 M | 1.28 M | 1.28 M | 1.28 M | 631 K | 631 K | 631 K | 631 K | 780 K | 780 K | 780 K | 780 K | 228 K | 228 K | 228 K | 228 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 12.3 K | 11.8 K | 11.8 K | 6.85 K | 6.85 K | 6.85 K | 6.85 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
2.71 M | 2.71 M | 2.62 M | 2.76 M | 2.76 M | 2.74 M | 2.64 M | 2.63 M | 2.37 M | 1.93 M | 1.28 M | 1.5 M | 1.32 M | 727 K | 590 K | 590 K | 590 K | 590 K | 113 K | 113 K | 113 K | 113 K | 59.4 K | 59.4 K | 59.4 K | 59.4 K | 192 K | 192 K | 192 K | 192 K | 40.1 K | 40.1 K | 40.1 K | 40.1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency